A customized LED UVA Illuminator

Cerus Corporation is dedicated to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. The company develops and supplies vital technologies and pathogen-protected blood components to blood centres, hospitals and, ultimately, patients who rely on safe blood.

The existing INTERCEPT® Blood system employs filtered UVA light from fluorescent lamps. Due to anticipated risks related to the availability of these lamps (supply chain, environmental), as well as potential benefits associated with light-emitting diode (LED) sources, Cerus has partnered with INO to develop a new generation of their INTERCEPT® Blood System’s illuminator based on LEDs.

What you'll learn

Discover how INO and Cerus tackled several key challenges in the development of this breakthrough system: 

• Development of LED technology: Transitioning from fluorescent lamps to cutting-edge LED solutions to ensure efficient and reliable pathogen inactivation.
• Precision engineering: Designing an illuminator that ensures uniform and controlled UVA dosing for safe blood transfusions.
• Thermal management: Overcoming heat dissipation issues to prolong LED lifespan and ensure product safety.
• Scalability: Moving from prototype validation to industrial-scale production.